Why the study?
Are impaired flow-mediated dilation and plasma biomarkers associated with coronary microvascular dysfunction in women with angina and no obstructive CAD?
Population
194 women with angina pectoris and no obstructive CAD and a reference population of 25 asymptomatic women…
Comparison
Measurement of flow-mediated dilation in the… vs Asymptomatic women without CAD and internal…
Design
Cross-sectional
Key result
Flow-mediated dilation and biomarkers of endothelial dysfunction did not correlate with coronary flow velocity reserve (Spearman ρ = -0.07, p = 0.45) in women with angina and no obstructive CAD.
Authors
Loading...
Peripheral FMD testing should not substitute for coronary assessment in INOCA; leaves open distinct endothelial pathways.
Cross-Sectional (n=219)
Are impaired flow-mediated dilation and plasma biomarkers associated with coronary microvascular dysfunction in women with angina and no obstructive CAD?
Effect estimate: Spearman ρ = -0.07
p-value: p=0.45
Peripheral endothelial function assessed by FMD does not correlate with coronary microvascular dysfunction in women with INOCA, indicating peripheral testing cannot substitute for coronary flow assessment.
Raft et al. (2017) conducted a cross-sectional in Angina and no obstructive coronary artery disease (n=219). Impaired flow-mediated dilation (FMD) and plasma biomarkers was evaluated on Correlation between coronary flow velocity reserve (CFVR) and flow-mediated dilation (FMD) (Spearman ρ = -0.07, p=0.45). Flow-mediated dilation and biomarkers of endothelial dysfunction did not correlate with coronary flow velocity reserve (Spearman ρ = -0.07, p = 0.45) in women with angina and no obstructive CAD.